A drug screen and a confirmatory test answer different questions. Screening is designed for efficient initial classification; confirmation uses a more specific method to identify defined drugs or metabolites after a non-negative screen or when definitive testing is otherwise needed.
This guide belongs to Drug-Test Detection and Accuracy.
What is an initial drug screen?
Initial testing often uses immunoassay technology. Antibodies respond to a target drug or group of chemically related compounds. This makes screening practical for many specimens, but response can vary among drugs within a class and unrelated compounds may sometimes cross-react.
A non-negative screen is commonly described as presumptive because it has not yet established the identity of a specific analyte through the program’s confirmatory method.
What is confirmatory testing?
Confirmation commonly uses gas or liquid chromatography combined with mass spectrometry. These methods separate compounds and identify targeted analytes using specific chemical information. The result is evaluated against confirmation criteria and reported according to the program.
Confirmation is highly specific, but it still answers only the question defined by the analyte list, specimen, validation, and cutoff. It does not automatically determine impairment, intent, exact dose, or exact time.
Typical two-stage workflow
- The specimen is collected, identified, and transported or tested under the applicable procedure.
- An initial method evaluates the ordered panel.
- A negative initial result is reported according to program rules.
- A non-negative initial result advances to specific confirmation when required.
- A qualified reviewer considers prescriptions, specimen validity, and legitimate explanations.
- The authorized recipient receives the final verified result.
When definitive testing may be ordered directly
Clinical or forensic settings may use definitive testing without a preceding class screen when the question requires specific analytes, the expected drug is poorly detected by immunoassay, or the consequences justify a targeted method. The order should still be medically or legally relevant rather than an indiscriminate search.
Why a home test is usually presumptive
Home and point-of-care devices provide rapid screening results. A non-negative result should be handled according to the instructions, often by sending a specimen to a laboratory. A person should not make a high-consequence decision solely from an unconfirmed home screen.
Can confirmation be wrong?
No analytical process is infallible. Pre-analytical errors, identity problems, contamination, an inappropriate analyte panel, interference, or reporting mistakes are possible. Quality systems, chain of custody, controls, validated methods, specimen retention, and split-specimen procedures reduce risk and create ways to review disputed results.
Key terminology
- Presumptive positive/non-negative: an initial finding requiring the program’s next step.
- Confirmed positive: a defined analyte met confirmation criteria.
- Verified result: the final classification after required medical review.
- Definitive test: a specific analytical test, often mass spectrometry based.
Questions to ask
- Was the result screened only or confirmed?
- Which analyte and metabolite were confirmed?
- Which method and cutoff applied?
- Was specimen validity evaluated?
- Who performed medical review?
- Is a retained or split specimen available under the program?
Continue with Presumptive Positive Results and Confirmed Positive Results.
Sources
- SAMHSA: Workplace Drug Testing Resources
- FDA: Drugs of Abuse Tests
- ASAM: Appropriate Use of Drug Testing
Last evidence review: October 29, 2026.